SD

Shankarrao Dhondiram Jadhav

Active Director Director DIN 09494827
DIN 09494827 First appointment Sep 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Shankarrao Dhondiram Jadhav

Data last updated:

Shankarrao Dhondiram Jadhav is a Director at Unncanny Biotech Private Limited (since 2022). The company operates in Pharma.

DIN 09494827
Primary Designation Director
Industry Pharma
First Appointment 16 Sep 2022
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Unncanny Biotech Private Limited U33119MH2018PTC313193
Director16 Sep 20222018Active

Board colleagues of Shankarrao Dhondiram Jadhav

Directorship timeline

Open interactive timeline →
Unncanny Biotech Private Limited
Premium access

Shareholding and investment profile for Shankarrao Dhondiram Jadhav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shankarrao Dhondiram Jadhav

Shankarrao Dhondiram Jadhav currently holds 1 directorship: Unncanny Biotech Private Limited (Director, since 16 Sep 2022).

Shankarrao Dhondiram Jadhav was first appointed on 16 Sep 2022 as Director at Unncanny Biotech Private Limited.

The current boards of Shankarrao Dhondiram Jadhav's companies include Amol Shankarao Jadhav (Unncanny Biotech Private Limited), Atul Vishnu Patil (Unncanny Biotech Private Limited), Hasan Majid Aga (Unncanny Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available